In 2010 the US Advisory Committee on Immunization Practices (ACIP) recommended that the pneumococcal seven-valent conjugate vaccine (PCV7) given routinely to children up to two years old be replaced by the pneumococcal thirteen-valent version (PCV13)
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/07/01/health-affairs-web-first-improved-pneumococcal-vaccine-costs-more-but-10-year-savings-projected/
Posted
Jul 01 2015, 01:02 PM
by
Health Affairs Blog